| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |